Results 11 to 20 of about 231,281 (308)
Drug treatment of COVID-19 infection
Current Opinion in Pulmonary Medicine, 2023 Purpose of review COVID-19 pandemic has caused more than 6.6 million deaths globally. Tremendous efforts have been committed for the development of new and repurposed drugs for the treatment of COVID-19. Although different international and national guidelines share consensus in the management of COVID-19 disease with different
Lui, Grace, Guaraldi, Giovanni
openaire +3 more sources
Secondary Publication: COVID-19 Pandemic: Drug Development and Treatment
Tokyo Women's Medical University Journal, 2021 Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019. It has been rapidly spreading worldwide ever since.
Fujiko Tsukahara, Yoshiro Maru
doaj +2 more sources
Drug Repurposing in the Treatment of COVID-19
Bezmialem Science, 2020 The use of drugs that have been previously defined for certain indications in new indications is defined as the repurposing/repositioning of the drug. The requirement of all clinical research steps that starts from healthy volunteers, due to the slowness of new drug discovery, longer time to reach the market, and high cost to develop a new drug, make ...
Soylu, Mehmet +2 more
core +4 more sources
COVID-19 Drug Treatment in China. [PDF]
Curr Pharmacol Rep, 2020 An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19.At present, the strategy of new use of old drugs is ...
Fan L, Jiang S, Yang X, Wang Z, Yang C.
europepmc +4 more sources
COVID-19: Drug Targets and Potential Treatments [PDF]
Journal of Medicinal Chemistry, 2020 Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19.
Gil, Carmen +10 more
openaire +3 more sources
Drug repurposing for the treatment of COVID-19
Journal of Pharmacological Sciences, 2022 Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and social and economic activities are gradually recovering.
Yuri Kato +7 more
openaire +3 more sources
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity [PDF]
, 2022 Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete description of specific immune biomarkers. We present here a comprehensive multi-omic blood atlas for patients with varying COVID-19 severity in an integrated ...
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium +1 more
core +3 more sources
Drugs for COVID-19 Treatment: A New Challenge
Applied Biochemistry and Biotechnology, 2023 COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly ...
Pratik Talukder +5 more
openaire +2 more sources
COVID-19: Current Challenges and Future Perspectives [PDF]
, 2022 On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both ...
core +1 more source
Molecules, 2022 In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the province of Wuhan, China.
Liliana Rodrigues +4 more
doaj +1 more source